Case 16-2013: A 12-year-old girl with irritability, hypersomnia, and somatic symptoms

New England Journal of Medicine

Volumn 368, Issue 21, 2013, Pages 2015-2024

  Bender, Suzanne L ^a,b   Sherry, Nicole A ^a,b   Masia, Ricard ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMYSIUM ANTIBODY; ESCITALOPRAM; SERTRALINE; HYDROCORTISONE;

ABDOMINAL PAIN; ANOREXIA; ANXIETY; ANXIETY DISORDER; ARM PAIN; ARTICLE; CASE REPORT; CELIAC DISEASE; CHILD; CONSTIPATION; DEPRESSION; DIZZINESS; DUODENUM; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; HYDRATION; HYPERSOMNIA; IRRITABILITY; LABORATORY TEST; LEG PAIN; PRIORITY JOURNAL; PSYCHOSOMATIC DISORDER; SCHOOL CHILD; SKIN TINGLING; SOMNOLENCE; ADDISON DISEASE; BLOOD; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; MAJOR DEPRESSION; PATHOLOGY; VOMITING;

ADDISON DISEASE; ANXIETY; CELIAC DISEASE; CHILD; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DISORDERS OF EXCESSIVE SOMNOLENCE; DUODENUM; FATIGUE; FEMALE; HUMANS; HYDROCORTISONE; IRRITABLE MOOD; VOMITING;

MLCS; MLOWN;

EID: 84877964921     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1208145     Document Type: Article

References (47)

1. Elsenbruch S. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011;25:386-94.
2. Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut 1999;45:Suppl 2:II1-II5.
3. Koloski NA, Jones M, Kalantar J, Weltman M, Zaguirre J, Talley NJ. The brain- gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut 2012;61:1284-90.
4. Campo JV, Jansen-McWilliams L, Comer DM, Kelleher KJ. Somatization in pediatric primary care: association with psychopathology, functional impairment, and use of services. J Am Acad Child Adolesc Psychiatry 1999;38:1093-101.
5. Wasserman AL, Whitington PF, Rivara FP. Psychogenic basis for abdominal pain in children and adolescents. J Am Acad Child Adolesc Psychiatry 1988;27:179-84.
6. Campo JV, Bridge J, Lucas A, et al. Physical and emotional health of mothers of youth with functional abdominal pain. Arch Pediatr Adolesc Med 2007;161:131-7.
7. Braaten E, Felopulos G. Nonverbal learning disorders and Asperger syndrome. In: Braaten E, Felopolus G, eds. Straight talk about psychological testing for kids. New York: Guilford Press, 2004:151-77.
8. Diagnostic and statistical manual of mental disorders, 4th ed. rev.: DSM-IV-R. Washington, DC: American Psychiatric Association, 2000.
9. Pynnönen PA, Isometsä ET, Aronen ET, Verkasalo MA, Savilahti E, Aalberg VA. Mental disorders in adolescents with celiac disease. Psychosomatics 2004;45:325-35.
10. García-Manzanares A, Lucendo AJ. Nutritional and dietary aspects of celiac disease. Nutr Clin Pract 2011;26:163-73.
11. Geringer ES, Querques J, Kolodziej MS, Burns TE, Stern TA. Diagnosis and treatment of depression in the intensive care unit patient. In: Irwin RS, Rippe JM, eds. Irwin and Rippe's intensive care medicine. 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2012:2087-98.
12. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from 'unipolar' to bipolar II: an 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995;52:114-23.
13. Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 1994;33:461-8.
14. Forty L, Smith D, Jones L, et al. Clinical differences between bipolar and unipolar depression. Br J Psychiatry 2008;192:388-9.
15. Benazzi F. Classifying mood disorders by age-at-onset instead of polarity. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:86-93.
16. Weissman MM, Wickramaratne P, Nomura Y, et al. Families at high and low risk for depression: a 3-generation study. Arch Gen Psychiatry 2005;62:29-36.
17. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18:765-94.
18. Rohde P, Lewinsohn PM, Seeley JR. Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol 1991;100:214-22.
19. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006:132:132-49.
20. Choe CJ, Emslie GJ, Mayes TL. Depression. Child Adolesc Psychiatric Clin N Am 2012;21:807-29.
21. Birmaher B, Brent D, Bernet W, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:1503-26.
22. Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of metaanalyses. Cognit Ther Res 2012;36:427-40.
23. Palermo TM, Eccleston C, Lewandowski AS, Williams AC, Morley S. Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review. Pain 2010;148:387-97.
24. Antidepressant medications for children and adolescents: information for parents and caregivers. Bethesda, MD: National Institute of Mental Health, 2011 (http://www.nimh.nih.gov/health/topics/child-and-adolescent-mental-health).
25. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006;63:332-9.
26. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a metaanalysis of randomized controlled trials. JAMA 2007;297:1683-96.
27. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004;292:807-20.
28. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007;64:1132-43. [Erratum, Arch Gen Psychiatry 2008;65:101.]
29. Brent DA, Emslie GJ, Clarke GN, et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study. Am J Psychiatry 2009;166:418-26.
30. Vitiello B, Emslie G, Clarke G, et al. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow- up study of the TORDIA sample. J Clin Psychiatry 2011;72:388-96.
31. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008;299:901-13.
32. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006;354:1243-52.
33. Hughes CW, Emslie GJ, Crismon ML, et al. Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry 2007;46:667-86.
34. Barrickman LL, Perry PJ, Allen AJ, et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995;34:649-57.
35. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1185-94.
36. O'Leary C, Walsh CH, Wieneke P, et al. Coeliac disease and autoimmune Addison's disease: a clinical pitfall. QJM 2002;95:79-82.
37. Myhre AG, Aarsetøy H, Undlien DE, Hovdenak N, Aksnes L, Husebye ES. High frequency of coeliac disease among patients with autoimmune adrenocortical failure. Scand J Gastroenterol 2003;38:511-5.
38. Biagi F, Campanella J, Soriani A, Vailati A, Corazza GR. Prevalence of coeliac disease in Italian patients affected by Addison's disease. Scand J Gastroenterol 2006;41:302-5.
39. Betterle C, Lazzarotto F, Spadaccino AC, et al. Celiac disease in North Italian patients with autoimmune Addison's disease. Eur J Endocrinol 2006;154:275-9.
40. Bleicken B, Hahner S, Ventz M, Quinkler M. Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci 2010;339:525-31.
41. Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med 2004;350:2068-79.
42. Løväs K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 2002;56:581-8.
43. Gurnell EM, Hunt PJ, Curran SE, et al. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab 2008;93:400-9.
44. Hahner S, Loeffler M, Fassnacht M, et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 2007;92:3912-22.
45. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999;341:1013-20.
46. Hunt PJ, Gurnell EM, Huppert FA, et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 2000;85:4650-6.
47. Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency. J Clin Endocrinol Metab 2009;94:3676-81.